CN100488535C - 一种番茄红素混合物 - Google Patents
一种番茄红素混合物 Download PDFInfo
- Publication number
- CN100488535C CN100488535C CNB2004100772041A CN200410077204A CN100488535C CN 100488535 C CN100488535 C CN 100488535C CN B2004100772041 A CNB2004100772041 A CN B2004100772041A CN 200410077204 A CN200410077204 A CN 200410077204A CN 100488535 C CN100488535 C CN 100488535C
- Authority
- CN
- China
- Prior art keywords
- milligrams
- account
- lycopene
- natural
- tomato
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims description 12
- 235000012661 lycopene Nutrition 0.000 claims abstract description 32
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 29
- 239000001751 lycopene Substances 0.000 claims abstract description 29
- 229960004999 lycopene Drugs 0.000 claims abstract description 29
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 29
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 28
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 17
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 12
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 12
- 239000011648 beta-carotene Substances 0.000 claims abstract description 12
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 12
- 229960002747 betacarotene Drugs 0.000 claims abstract description 12
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 12
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 12
- 235000019198 oils Nutrition 0.000 claims abstract description 9
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 8
- 235000002677 phytofluene Nutrition 0.000 claims abstract description 8
- OVSVTCFNLSGAMM-KGBODLQUSA-N cis-phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/C=C/C=C(C)/CCC=C(/C)CCC=C(C)C)C)C)C)C OVSVTCFNLSGAMM-KGBODLQUSA-N 0.000 claims abstract description 5
- OVSVTCFNLSGAMM-UZFNGAIXSA-N phytofluene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=C\C=C(/C)\C=C\C=C(C)CCC=C(C)CCC=C(C)C OVSVTCFNLSGAMM-UZFNGAIXSA-N 0.000 claims abstract description 5
- ZYSFBWMZMDHGOJ-SGKBLAECSA-N phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)C=CC=C(/C)CCC=C(C)C)C)C)C)C ZYSFBWMZMDHGOJ-SGKBLAECSA-N 0.000 claims abstract description 5
- ZIUDAKDLOLDEGU-UHFFFAOYSA-N trans-Phytofluen Natural products CC(C)=CCCC(C)CCCC(C)CC=CC(C)=CC=CC=C(C)C=CCC(C)CCCC(C)CCC=C(C)C ZIUDAKDLOLDEGU-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940068065 phytosterols Drugs 0.000 claims abstract description 4
- 241000227653 Lycopersicon Species 0.000 claims abstract 9
- 240000003768 Solanum lycopersicum Species 0.000 claims description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 239000003549 soybean oil Substances 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 150000002664 lycopenes Chemical class 0.000 claims description 4
- 235000011765 phytoene Nutrition 0.000 claims description 4
- 150000003032 phytoenes Chemical class 0.000 claims description 3
- 150000003033 phytofluenes Chemical class 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- 235000019149 tocopherols Nutrition 0.000 claims description 3
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 3
- 208000010125 myocardial infarction Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- -1 phytopene Chemical compound 0.000 abstract 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000009329 organic farming Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000008171 pumpkin seed oil Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100772041A CN100488535C (zh) | 2004-12-09 | 2004-12-09 | 一种番茄红素混合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100772041A CN100488535C (zh) | 2004-12-09 | 2004-12-09 | 一种番茄红素混合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1650951A CN1650951A (zh) | 2005-08-10 |
CN100488535C true CN100488535C (zh) | 2009-05-20 |
Family
ID=34869059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100772041A Active CN100488535C (zh) | 2004-12-09 | 2004-12-09 | 一种番茄红素混合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100488535C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0819959D0 (en) | 2008-10-31 | 2008-12-10 | Provexis Natural Products Ltd | Fruit extracts |
EP2844083B1 (en) | 2012-04-23 | 2018-07-25 | University Of Oslo | Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract |
GB201223365D0 (en) | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
CN105682684A (zh) * | 2013-12-11 | 2016-06-15 | 健永生技股份有限公司 | 类胡萝卜素的医药组合物 |
JP2015181362A (ja) * | 2014-03-20 | 2015-10-22 | 一般財団法人バイオダイナミックス研究所 | 高機能性食用油とその製造法 |
JP7104032B2 (ja) | 2016-11-02 | 2022-07-20 | プロヴェクシス ナチュラル プロダクツ リミテッド | 大気汚染の悪影響に対する水溶性トマト抽出物の保護 |
CN108669557A (zh) * | 2018-05-20 | 2018-10-19 | 苏州工业园区联创生物科技有限公司 | 含有天然番茄萃取液南瓜籽油的软胶囊剂型及其制备方法 |
-
2004
- 2004-12-09 CN CNB2004100772041A patent/CN100488535C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1650951A (zh) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008154294A1 (en) | Method and composition for providing controlled delivery of biologically active substances | |
WO2005110375A8 (en) | Nutritional supplement for treatment of ocular diseases | |
EP1833498B1 (en) | Oral composition for enhancing skin properties | |
ES2351141B1 (es) | Aceites funcionales a base de aceite de oliva. | |
MX2010011544A (es) | Composiciones que contienen lipidos y metodos para utilizar las mismas. | |
CN100488535C (zh) | 一种番茄红素混合物 | |
SK12398A3 (en) | Two-stage preparation | |
US11576935B2 (en) | Non-winterized, standardized marine source oil products and methods of making thereof | |
Subermaniam et al. | Virgin Coconut Oil (VCO) decreases the level of malondialdehyde (MDA) in the cardiac tissue of experimental Sprague-Dawley rats fed with heated palm oil | |
DE202018105987U1 (de) | Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten | |
Kharb et al. | Nutriceuticals in health and disease prevention | |
CN101327199A (zh) | 作为抗高血压药的类胡萝卜素 | |
CN102940011A (zh) | 一种含有橄榄提取物的饼干 | |
CN105146543A (zh) | 一种提高免疫力、治疗三高的磷虾油复方制剂 | |
JP6450317B2 (ja) | Dha及びepaを含む軟カプセル | |
DE202018105422U1 (de) | Zusammensetzung zur Linderung von Gelenkschmerzen unter Verwendung von Hyaluronsäure und Eierschalenmembrankomponenten | |
RU2390158C1 (ru) | Салатное масло | |
CA2968523C (en) | Formulation for effective tocotrienol delivery | |
CN108065361A (zh) | 一种虾青素复合制剂 | |
Chatterjee | Therapeutic fruit peels: Their role in preventing lifestyle disorders | |
CN109123674A (zh) | 一种黑果枸杞复方缓解视疲劳片以及其制备工艺 | |
van Rooyen | Bioactive compounds in red palm oil can modulate mechanisms of actions in in vitro anoxic perfused rat hearts | |
Papandreou et al. | An updated mini review on grapefruit: Interactions with drugs, obesity and cardiovascular Risk factors | |
CN104783160A (zh) | 一种β-胡萝卜素复合制剂 | |
DE212014000004U1 (de) | Abgabesystem für Sägepalmextrakt und Carotinoid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUO FUFENG Free format text: FORMER OWNER: NINGBO JIANYONG BIOLOGY SCIENCE CO., LTD. Effective date: 20071228 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20071228 Address after: Shanghai City, Pudong New Area Waigaoqiao Taigu Road No. 18 room 605 post encoding: 200131 Applicant after: Guo Fufeng Address before: 3B1 post encoding No. 7 Zhejiang Avenue business city of Ningbo province Ningbo Free Trade Zone: 315800 Applicant before: NINGBO JIANYONG BIOLOGICAL SCIENCE AND TECHNOLOGYCO., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HEALTH EVER BIO-TECH CO., LTD. Free format text: FORMER OWNER: GUO FUFENG Effective date: 20130201 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200131 PUDONG NEW AREA, SHANGHAI TO: TAIWAN, CHINA |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130201 Address after: Taiwan, Taipei, China Wenshan Nanjing East Road, paragraph 186, No. 11, building 4, 9 Patentee after: HEALTH-EVER BIOTECH CO.,LTD. Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Taigu Road No. 18 room 605 Patentee before: Guo Fufeng |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210513 Address after: Room 1203-4, 12 / F, Hong Kong Trade Centre, 161-167 des Voeux Road Central, Hong Kong, China Patentee after: Dingshunxing Co.,Ltd. Address before: Taiwan, Taipei, China Wenshan Nanjing East Road, paragraph 186, No. 11, building 4, 9 Patentee before: Health-Ever Biotech Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20221130 Address after: Singapore, Singapore City Patentee after: Jianyong Biotechnology International Pte. Ltd. Address before: Room 1203-4, 12 / F, Hong Kong Trade Centre, 161-167 des Voeux Road Central, Hong Kong, China Patentee before: Dingshunxing Co.,Ltd. |
|
TR01 | Transfer of patent right |